This inventor holds 21 USPTO granted patents and 9 published patent applications, plus 6 CIPO patents and 5 EPO patents, primarily in Cardiovascular Health. Top assignees: Mochida Pharmaceutical Co., Ltd., Sankyo Company, Limited, Otsuka Pharmaceutical Company, Limited. Active years: 2002-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (2003 - 2016)
- Takarzuka, JP (2017)
- Takaruzuka, JP (2017)
- Takarazuka, JP (2002 - 2020)
Company Filing History:
10 out of 229 
3 out of 613 
2 out of 846 
Years Active: 2002-2020
Areas of Expertise:
Title: **Yuji Matsuzawa: A Pioneer in Cardiovascular Innovation**
Introduction
Yuji Matsuzawa, an accomplished inventor based in Takarazuka, Japan, has made significant strides in the field of cardiovascular health, holding a remarkable 21 patents to his name. His innovative approach to addressing cardiovascular diseases has positioned him as a key figure in medical research and development.
Latest Patents
Among his latest contributions is a groundbreaking composition aimed at preventing the occurrence of cardiovascular events in patients with multiple risk factors, particularly those suffering from hypercholesterolemia. This composition is noteworthy for its expected prophylactic effects, even when patients are already undergoing treatment with HMG-CoA reductase inhibitors (HMG-CoA RI). These formulations showcase Matsuzawa’s commitment to advancing medical solutions for complex cardiovascular conditions.
Career Highlights
Yuji Matsuzawa has built a distinguished career, contributing to major pharmaceutical companies, notably Mochida Pharmaceutical Co., Ltd. and Sankyo Company, Limited. His work within these organizations has enabled him to pioneer innovative medical solutions, enhancing the quality of life for individuals at risk of cardiovascular diseases.
Collaborations
Throughout his career, Matsuzawa has collaborated with esteemed colleagues, including Mitsuhiro Yokoyama and Hideki Origasa. These partnerships have played a crucial role in driving forward his research initiatives and expanding the impact of his inventions in the pharmaceutical landscape.
Conclusion
Yuji Matsuzawa’s contributions to innovation in cardiovascular health underscore his importance as an inventor and thought leader in the medical field. His extensive portfolio of patents and collaborations reflects not only his dedication to improving patient outcomes but also his role in advancing scientific research focused on preventing cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile